Dr. Lal Path Labs Ltd. Jun 2026 Quarterly Results Analysis
Earnings Analysis Dashboard – LALPATHLAB
Structured AI analysis of company financial results designed to help traders and investors quickly understand key performance trends.
Type of Announcement
The announcement outlines the outcome of the Board Meeting held on July 24, 2026, which includes approval of un-audited financial results, interim dividend declaration, and stock options grant.Key Financial Numbers (Quarter)
| Metric | Current Quarter (Jun 2026) | Previous Quarter (Mar 2026) | Same Quarter Last Year (Jun 2025) |
|---|---|---|---|
| Revenue (₹ Crs.) | 797.7 | 702.7 | 669.8 |
| Net Profit (₹ Crs.) | 170.5 | 132.2 | 134.0 |
| EPS | 10.15 | 7.86 | 7.94 |
| EBITDA Margin (%) | N/A | N/A | N/A |
EPS (Earnings Per Share) shows how much profit a company generates for each share. Higher EPS usually indicates stronger profitability and better earnings power for shareholders.
What EBITDA Margin Means
EBITDA Margin measures operating profitability before interest, tax, depreciation and amortization. A higher margin suggests the company is generating stronger operating profits from its revenue.
Revenue Trend
Profit Trend
Quick Interpretation
- QoQ revenue trend: Strong growth (+13.5%)
- YoY revenue trend: Improved (+19.1%)
Major Corporate Events
- Declaration of interim dividend of ₹5 per equity share.
- Grant of stock options under the Employee Restricted Stock Unit Plan 2025.
Trading Signals
- Positive Factors: Strong quarterly increase in revenue and net profit.
- Negative Factors: N/A
Overall Sentiment
About Stock Insights NSE
Stock Insights NSE provides AI-powered analysis of NSE-listed companies including quarterly results, dividends, IPOs, mutual fund holdings and FII/DII investment activity.
You can also access these insights through the Stock Insights NSE Android app for quarterly results, FII/DII activity, dividends, IPOs and mutual fund portfolio updates.
Download Stock Insights NSE
Get instant access to AI-powered quarterly results analysis, FII/DII activity, dividend announcements, IPO updates, mutual fund holdings and other market insights directly on your Android device.
Download the Stock Insights NSE app on Google Play
Related Market Resources
Frequently Asked Questions
How much revenue did Dr. Lal Path Labs Ltd. report?
Dr. Lal Path Labs Ltd. reported revenue of ₹797.70 Cr during Jun 2026.
What was the EPS of Dr. Lal Path Labs Ltd.?
EPS reported was 10.15.
What was the net profit of Dr. Lal Path Labs Ltd.?
Net profit was ₹170.50 Cr.
What were the Dr. Lal Path Labs Ltd. Jun 2026 quarterly results?
Dr. Lal Path Labs Ltd. reported revenue of ₹797.70 Cr, net profit of ₹170.50 Cr, EPS of 10.15 for Jun 2026.
How can investors compare the latest Dr. Lal Path Labs Ltd. results with the previous quarter?
Compare the revenue, net profit and EPS figures shown in the financial results table and trend sections of this report.
Disclaimer
This report has been analysed and generated using AI based on publicly available corporate announcements and financial disclosures published by the company on NSE INDIA Website.
We are not registered with SEBI as an investment advisor or research analyst. This report is provided strictly for informational and educational purposes only.
Investors should not treat this analysis as financial advice, stock recommendation, or investment guidance. Always conduct your own research or consult a SEBI-registered financial advisor before making investment decisions.
The platform does not guarantee accuracy, completeness, or timeliness of the extracted information.